Wednesday, April 22, 2009 6:12:38 PM
1) I don't know what Entremed has or has not said about the partnering process while engaged in it, but if one has to go that far afield to find an exception, I'll stick to my case that any discussion of partnering talks other than the most generic possible is generally not done.
2) <<Discuss plans. Discuss strategy. Discuss what is going on that is reportable. Provide timelines that are realistic. Inform the shareholder of information that is available for dissemination. Inform the shareholder of what exit strategies are in place should none of their current plans materialize. Perform "public relations". Build confidence in the company during times of trouble>>
I think this has been done as much as is safely possible. I've already addressed the issue of timelines in another post--it could be to their detriment to say anything more than they already have. Is there really anything that they can say in general, generic terms that would "build confidence?" I think words are pretty irrelevant now, and they know it. Either they pull off a deal or two, or they'll have to sell the company to the highest bidder(s). Would it restore your confidence, or anyone else's, to hear them say that?
We will continue to disagree about the etiology of Cortex's current dilemma.
NeuroInvestment
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM